Clinical Trials for BlossomHill Therapeutics

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: BlossomHill Therapeutics

Clinical Trials (2)

A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

PHASE1/PHASE2Recruiting

266 participants

Started: Jan 9, 2025 · Completed: Jul 31, 2029

1 condition1 sponsor30 locations

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

PHASE1Recruiting

170 participants

Started: Jun 19, 2024 · Completed: Jun 30, 2027

6 conditions1 sponsor13 locations